We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+6.99%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.36B
AUM Growth
+$242M
Cap. Flow
+$103M
Cap. Flow %
4.35%
Top 10 Hldgs %
34.74%
Holding
3,215
New
293
Increased
1,348
Reduced
581
Closed
158
Avg Time Held Equity + Options
2.6 years
Top 10 Avg Time Held Equity + Options
1.9 years
Top 20 Avg Time Held Equity + Options
2.2 years
Avg Time Held Equity only
2.6 years
Top 10 Avg Time Held Equity only
1.9 years
Top 20 Avg Time Held Equity only
2.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.15%
2 Technology 15.95%
3 Financials 7.59%
4 Healthcare 5.97%
5 Communication Services 5.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AMRC icon
2676
Ameresco
AMRC
$1.07B
$1K ﹤0.01%
8
– –
2021 Q1
1 quarter
ANAB icon
2677
AnaptysBio
ANAB
$1.46B
$1K ﹤0.01%
42
– –
2019 Q4
6 quarters
ARCT icon
2678
Arcturus Therapeutics
ARCT
$320M
$1K ﹤0.01%
20
– –
2021 Q1
1 quarter
ARTNA icon
2679
Artesian Resources
ARTNA
$342M
$1K ﹤0.01%
28
– –
2020 Q3
3 quarters
ARVN icon
2680
Arvinas
ARVN
$468M
$1K ﹤0.01%
17
– –
2021 Q1
1 quarter
ASIX icon
2681
AdvanSix
ASIX
$446M
$1K ﹤0.01%
23
+8
+53% +$240
2016 Q4
18 quarters
ASTS icon
2682
AST SpaceMobile
ASTS
$13.3B
$1K ﹤0.01%
+54
New +$486
2021 Q2
0 quarters
ATEC icon
2683
Alphatec Holdings
ATEC
$1.69B
$1K ﹤0.01%
+61
New +$941
2021 Q2
0 quarters
ATKR icon
2684
Atkore
ATKR
$3.21B
$1K ﹤0.01%
14
– –
2021 Q1
1 quarter
ATNI icon
2685
ATN International
ATNI
$398M
$1K ﹤0.01%
11
– –
2016 Q4
18 quarters
ATOM icon
2686
Atomera
ATOM
$130M
$1K ﹤0.01%
35
– –
2021 Q1
1 quarter
AUTL icon
2687
Autolus Therapeutics
AUTL
$458M
$1K ﹤0.01%
+180
New +$1.12K
2021 Q2
0 quarters
AVDL
2688
DELISTED
Avadel Pharmaceuticals
AVDL
$1K ﹤0.01%
+128
New +$1.02K
2021 Q2
0 quarters
AVIR icon
2689
Atea Pharmaceuticals
AVIR
$363M
$1K ﹤0.01%
+43
New +$1.29K
2021 Q2
0 quarters
DCH icon
2690
Dauch Corp
DCH
$1.21B
$1K ﹤0.01%
+115
New +$1.21K
2021 Q2
0 quarters
AXSM icon
2691
Axsome Therapeutics
AXSM
$8.47B
$1K ﹤0.01%
17
– –
2021 Q1
1 quarter
AZEK icon
2692
DELISTED
The AZEK Co
AZEK
$1K ﹤0.01%
31
-419
-93% -$18.8K
2020 Q4
2 quarters
BAB icon
2693
Invesco Taxable Municipal Bond ETF
BAB
$858M
$1K ﹤0.01%
15
-1
-6% -$33
2018 Q4
10 quarters
BAR icon
2694
GraniteShares Gold Shares
BAR
$1.36B
$1K ﹤0.01%
+37
New +$667
2021 Q2
0 quarters
BEAM icon
2695
Beam Therapeutics
BEAM
$2.55B
$1K ﹤0.01%
10
– –
2020 Q4
2 quarters
BGC icon
2696
BGC Group
BGC
$5.41B
$1K ﹤0.01%
151
– –
2019 Q2
8 quarters
BHR icon
2697
Braemar Hotels & Resorts
BHR
$95.5M
$1K ﹤0.01%
+225
New +$1.39K
2021 Q2
0 quarters
BOLT icon
2698
Bolt Biotherapeutics
BOLT
$8.17M
$1K ﹤0.01%
+3
New +$1.22K
2021 Q2
0 quarters
CAC icon
2699
Camden National
CAC
$944M
$1K ﹤0.01%
20
– –
2021 Q1
1 quarter
CALX icon
2700
Calix
CALX
$2.34B
$1K ﹤0.01%
13
– –
2021 Q1
1 quarter

Similar funds

Parallel Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Parallel Advisors held 3,215 positions worth $2.36B, up 11% from $2.12B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $103M of net new capital in Q2 2021, opening 293 new positions and adding to 1,348 existing holdings. Its largest new stake was U.S. Core Equity 2 Portfolio ETF Class Shares: 118,367 shares worth $3.19M.

By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 53% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares US Treasury Bond ETF, an estimated $8.53M trimmed.

  • Parallel Advisors's largest Q2 2021 buy was U.S. Core Equity 2 Portfolio ETF Class Shares: 118,367 shares worth $3.19M.
  • Parallel Advisors added most to State Street Energy Select Sector SPDR ETF in Q2 2021, an estimated $14.3M increase.
  • Parallel Advisors's biggest Q2 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $8.53M.
  • Parallel Advisors fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $365K.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.36B portfolio in Q2 2021.
  • Parallel Advisors opened 293 new positions and closed 158 in Q2 2021.
  • Parallel Advisors's portfolio value rose 11% quarter-over-quarter to $2.36B.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.